NCT03740334 2025-11-21Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLDana-Farber Cancer InstitutePhase 1 Active not recruiting45 enrolled
NCT00819546 2025-02-27RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSDana-Farber Cancer InstitutePhase 1 Active not recruiting29 enrolled